Skip to content
NASDAQ · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · SMALL CAP

United Guardian Inc. UG

16 fiscal years on record · USD · FY2025 reported · SEC filings only
$10.5M
▼ 13.4% YoY
$2.1M
▼ 35.2% YoY
$1.9M
▼ 37.1% YoY
In brief

What this company does

All the products that we market, except for Renacidin®, are produced at our facility in Hauppauge, New York. One of our most important product lines is our Lubrajel line of multifunctional hydrogel formulations, which are designed to provide sensory enhancement, lubrication, hydration, and texture to both personal care and medical products. Our pharmaceutical products are sold primarily to three national full-line drug wholesalers which in turn supply those products to pharmacies, physicians, and hospitals. We operate as a single business segment.

Written from the business description in United-Guardian, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 March 2026. Every sentence was checked against that document before publication.

Growth
USD 10.5M
Revenue, FY2025 · full 16-year series below
Revenue $M Net income $M
FY2025 · Revenue 10.5 · Net income 2.1
8M201020122014201620182020202220242025
Compound annual growth
−6.0%
−0.8%
−2.8%
−1.7%
−6.4%
−8.6%
−7.5%
−3.9%
+2.1%
+12.5%
−0.2%
−11.4%
−4.0%
−5.0%
−4.9%
−7.1%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at −0.8% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
20 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 21.3% · Net 20.0%
10000%20000%30000%201020122014201620182020202220242025
ROE
FY2025 · ROE 18.2%
20%40%201020122014201620182020202220242025

Each USD of equity produced 18 cents of profit this year.

Cash & shareholders
USD 2.8M
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 1.9
2M4M201020122014201620182020202220242025
Net buybacks $M Dividends $M
FY2025 · Dividends 2.8 · Net buybacks —
4M8MDividendsNet buybacks201020122014201620182020202220242025

USD 2.8M in dividends — 131% of the year's profit, so the payout drew on cash built up earlier.

Total assetsUSD 13.1M
EquityUSD 11.2M
CashUSD 1.3M
Current ratio7.31×

Equity funds 86% of total assets.

The 16-year record
16 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 2025202420232022202120202019201820172016201520142013201220112010
Revenue $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Operating income $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
EBITDA $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Net income $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Free cash flow $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
EPS, diluted $····1.010.721.040.950.840.561.000.881.281.051.030.80
Dividend / sh $·0.600.10···1.101.05········
Payout %1318518122111108106111169133100917612978121
ROE %18.227.925.026.946.231.544.239.030.518.231.428.043.635.834.729.1
Shares out B0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 63 reconciliationsAUDITED

Reconciled in 16 of 19 fiscal years. 16 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityPerfumes, Cosmetics & Other Toilet Preparations
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2010

Share this section

Download image